AbbVie (ABBV) Tax Provisions (2012 - 2026)

AbbVie (ABBV) has reported Tax Provisions for 15 consecutive years, with $662.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Tax Provisions rose 7.99% year-over-year to $662.0 million in Q2 2026; TTM through Jun 2026 was $2.4 billion, a 421.59% increase from a year earlier, with the FY2025 full-year figure at $2.4 billion, up 514.74% from the prior year.
• Tax Provisions was $662.0 million for Q2 2026 at AbbVie, up from $342.0 million in the prior quarter.
• Over five years, Tax Provisions peaked at $853.0 million in Q4 2025 and troughed at -$2.2 billion in Q4 2024.
• A 5-year average of $341.4 million and a median of $470.5 million in 2022 frame the typical range for Tax Provisions.
• The widest YoY moves for Tax Provisions: up 202.33% in 2024, down 678.87% in 2024.
• Over 5 years, Tax Provisions stood at $493.0 million in 2022, then fell by 21.3% to $388.0 million in 2023, then sank by 678.87% to -$2.2 billion in 2024, then soared by 137.98% to $853.0 million in 2025, then decreased by 22.39% to $662.0 million in 2026.
• The last three Tax Provisions figures came in at $662.0 million (Q2 2026), $342.0 million (Q1 2026), and $853.0 million (Q4 2025), per Business Quant data.